{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T07:21:09Z","timestamp":1787728869183,"version":"build-2784847793"},"reference-count":70,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Emergency Medicine"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.ajem.2026.02.027","type":"journal-article","created":{"date-parts":[[2026,2,18]],"date-time":"2026-02-18T00:24:24Z","timestamp":1771374264000},"page":"1-9","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Intramuscular droperidol, olanzapine, midazolam, or lorazepam to treat methamphetamine intoxication in the emergency department"],"prefix":"10.1016","volume":"104","author":[{"given":"Jon B.","family":"Cole","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paige A.","family":"DeVries","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jamie L.","family":"O'Flaherty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ann M.","family":"Arens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Travis D.","family":"Olives","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc L.","family":"Martel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James R.","family":"Miner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian E.","family":"Driver","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajem.2026.02.027_bb0005","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1080\/15563650.2020.1861287","article-title":"Methamphetamine exposures reported to United States poison control centers, 2000-2019","volume":"59","author":"Chen","year":"2021","journal-title":"Clin Toxicol (Phila)"},{"key":"10.1016\/j.ajem.2026.02.027_bb0010","doi-asserted-by":"crossref","first-page":"4050932","DOI":"10.1155\/2017\/4050932","article-title":"Methamphetamine use and emergency department utilization: 20 years later","volume":"2017","author":"Richards","year":"2017","journal-title":"J Addict"},{"key":"10.1016\/j.ajem.2026.02.027_bb0015","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1016\/j.ajem.2018.01.001","article-title":"Methamphetamine use and heart failure: prevalence, risk factors, and predictors","volume":"36","author":"Richards","year":"2018","journal-title":"Am J Emerg Med"},{"key":"10.1016\/j.ajem.2026.02.027_bb0020","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1016\/j.jemermed.2013.04.061","article-title":"Cardiac complications of adult methamphetamine exposures","volume":"45","author":"Hawley","year":"2013","journal-title":"J Emerg Med"},{"key":"10.1016\/j.ajem.2026.02.027_bb0025","doi-asserted-by":"crossref","DOI":"10.1186\/s12883-020-01967-y","article-title":"Intracerebral hemorrhage: who gets tested for methamphetamine use and why might it matter?","volume":"20","author":"Osman","year":"2020","journal-title":"BMC Neurol"},{"key":"10.1016\/j.ajem.2026.02.027_bb0030","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/S0736-4679(99)00009-8","article-title":"Methamphetamine-related stroke: four cases","volume":"17","author":"Perez","year":"1999","journal-title":"J Emerg Med"},{"key":"10.1016\/j.ajem.2026.02.027_bb0035","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1080\/15504263.2020.1786617","article-title":"Rhabdomyolysis, methamphetamine, amphetamine and MDMA use: associated factors and risks","volume":"16","author":"Richards","year":"2020","journal-title":"J Dual Diagn"},{"key":"10.1016\/j.ajem.2026.02.027_bb0040","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1111\/nep.13762","article-title":"Methamphetamine intoxication and acute kidney injury: a prospective observational case series","volume":"25","author":"Isoardi","year":"2020","journal-title":"Nephrology"},{"key":"10.1016\/j.ajem.2026.02.027_bb0045","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.ajem.2020.12.083","article-title":"Hyperthermia associated with methamphetamine and cocaine use: a case series","volume":"42","author":"Marco","year":"2021","journal-title":"Am J Emerg Med"},{"key":"10.1016\/j.ajem.2026.02.027_bb0050","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1111\/1742-6723.13219","article-title":"Methamphetamine presentations to an emergency department: management and complications","volume":"31","author":"Isoardi","year":"2019","journal-title":"Emerg Med Australas"},{"key":"10.1016\/j.ajem.2026.02.027_bb0055","doi-asserted-by":"crossref","first-page":"17","DOI":"10.5811\/westjem.2011.9.6864","article-title":"Verbal de-escalation of the agitated patient: consensus statement of the American Association for Emergency Psychiatry Project BETA de-escalation workgroup","volume":"13","author":"Richmond","year":"2012","journal-title":"West J Emerg Med"},{"key":"10.1016\/j.ajem.2026.02.027_bb0060","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/j.ajem.2021.09.029","article-title":"The use of verbal de-escalation in intoxicated emergency department patients","volume":"56","author":"Klein","year":"2022","journal-title":"Am J Emerg Med"},{"key":"10.1016\/j.ajem.2026.02.027_bb0065","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1007\/s13181-020-00821-4","article-title":"Pediatric methamphetamine toxicity: clinical manifestations and therapeutic use of antipsychotics-one institution\u2019s experience","volume":"17","author":"Malashock","year":"2021","journal-title":"J Med Toxicol"},{"key":"10.1016\/j.ajem.2026.02.027_bb0070","doi-asserted-by":"crossref","first-page":"26","DOI":"10.5811\/westjem.2011.9.6866","article-title":"The psychopharmacology of agitation: consensus statement of the american association for emergency psychiatry project Beta psychopharmacology workgroup","volume":"13","author":"Wilson","year":"2012","journal-title":"West J Emerg Med"},{"key":"10.1016\/j.ajem.2026.02.027_bb0075","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2025.51683","article-title":"Oral medications for treating agitation in a safety net emergency department","volume":"8","author":"Cole","year":"2025","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.ajem.2026.02.027_bb0080","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.annemergmed.2018.06.001","article-title":"The characteristics and prevalence of agitation in an Urban County emergency department","volume":"72","author":"Miner","year":"2018","journal-title":"Ann Emerg Med"},{"key":"10.1016\/j.ajem.2026.02.027_bb0085","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1002\/jppr.1522","article-title":"Management of behavioural emergencies: a prospective observational study in Australian emergency departments","volume":"49","author":"Yap","year":"2019","journal-title":"J Pharm Pract Res"},{"key":"10.1016\/j.ajem.2026.02.027_bb0090","doi-asserted-by":"crossref","first-page":"9","DOI":"10.9740\/mhc.2022.01.009","article-title":"Evaluating the impact of an emergency department protocol that guides management of methamphetamine-induced agitation and psychosis","volume":"12","author":"Nguyen","year":"2022","journal-title":"Ment Health Clin"},{"key":"10.1016\/j.ajem.2026.02.027_bb0095","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/1471-227X-10-14","article-title":"The impact of a standardised intramuscular sedation protocol for acute behavioural disturbance in the emergency department","volume":"10","author":"Calver","year":"2010","journal-title":"BMC Emerg Med"},{"key":"10.1016\/j.ajem.2026.02.027_bb0100","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.annemergmed.2016.09.021","article-title":"Droperidol or olanzapine, intramuscularly or intravenously, monotherapy or combination therapy for sedating acute behavioral disturbance","volume":"69","author":"Isbister","year":"2017","journal-title":"Ann Emerg Med"},{"key":"10.1016\/j.ajem.2026.02.027_bb0105","doi-asserted-by":"crossref","first-page":"e188","DOI":"10.1016\/j.jemermed.2024.03.019","article-title":"Risk factors and emergency department outcomes in methamphetamine-associated cardiomyopathy: a case-control study","volume":"67","author":"Suto","year":"2024","journal-title":"J Emerg Med"},{"key":"10.1016\/j.ajem.2026.02.027_bb0110","article-title":"Methamphetamine-induced hyperthermia with fatal outcome","volume":"185","author":"Fahrendorff","year":"2023","journal-title":"Ugeskr Laeger"},{"key":"10.1016\/j.ajem.2026.02.027_bb0115","doi-asserted-by":"crossref","first-page":"257.e1","DOI":"10.1016\/j.ajem.2020.06.081","article-title":"Methamphetamine-associated pulseless electrical activity in a young child","volume":"39","author":"Tsai","year":"2021","journal-title":"Am J Emerg Med"},{"key":"10.1016\/j.ajem.2026.02.027_bb0120","doi-asserted-by":"crossref","first-page":"147","DOI":"10.3109\/15563659409000444","article-title":"Fatal and nonfatal methamphetamine intoxication in the intensive care unit","volume":"32","author":"Chan","year":"1994","journal-title":"J Toxicol Clin Toxicol"},{"key":"10.1016\/j.ajem.2026.02.027_bb0125","series-title":"Goldfrank\u2019s Toxicologic emergencies, 11th Edition","first-page":"1099","article-title":"Amphetamines","author":"Spyres","year":"2019"},{"key":"10.1016\/j.ajem.2026.02.027_bb0130","series-title":"Goldfrank\u2019s Toxicologic emergencies, 11th Edition","first-page":"1135","article-title":"Chapter A26: Benzodiazepines","author":"Garlich Horner","year":"2019"},{"key":"10.1016\/j.ajem.2026.02.027_bb0135","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1111\/add.13780","article-title":"Intravenous midazolam-droperidol combination, droperidol or olanzapine monotherapy for methamphetamine-related acute agitation: subgroup analysis of a randomized controlled trial","volume":"112","author":"Yap","year":"2017","journal-title":"Addiction"},{"key":"10.1016\/j.ajem.2026.02.027_bb0140","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1097\/00063110-199709000-00003","article-title":"Methamphetamine toxicity: treatment with a benzodiazepine versus a butyrophenone","volume":"4","author":"Richards","year":"1997","journal-title":"Eur J Emerg Med"},{"key":"10.1016\/j.ajem.2026.02.027_bb0145","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.annemergmed.2017.07.021","article-title":"Unsuspected critical illness among emergency department patients presenting for acute alcohol intoxication","volume":"71","author":"Klein","year":"2018","journal-title":"Ann Emerg Med"},{"key":"10.1016\/j.ajem.2026.02.027_bb0150","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.ajem.2020.12.079","article-title":"Medical needs of emergency department patients presenting with acute alcohol and drug intoxication","volume":"42","author":"Stang","year":"2021","journal-title":"Am J Emerg Med"},{"key":"10.1016\/j.ajem.2026.02.027_bb0155","first-page":"1402","article-title":"A retrospective review of the use and safety of droperidol in a large, high-risk, inner-city emergency department patient population","volume":"9","author":"Chase","year":"2002","journal-title":"Acad Emerg Med"},{"key":"10.1016\/j.ajem.2026.02.027_bb0160","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.annemergmed.2016.08.008","article-title":"A prospective observational study of patients receiving intravenous and intramuscular olanzapine in the emergency department","volume":"69","author":"Cole","year":"2017","journal-title":"Ann Emerg Med"},{"key":"10.1016\/j.ajem.2026.02.027_bb0165","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1016\/j.ajem.2019.09.007","article-title":"Effectiveness and safety of droperidol in a United States emergency department","volume":"38","author":"Gaw","year":"2020","journal-title":"Am J Emerg Med"},{"key":"10.1016\/j.ajem.2026.02.027_bb0170","doi-asserted-by":"crossref","first-page":"1838","DOI":"10.1093\/ajhp\/zxaa271","article-title":"Reintegrating droperidol into emergency medicine practice","volume":"77","author":"Mattson","year":"2020","journal-title":"Am J Health-Syst Pharm"},{"key":"10.1016\/j.ajem.2026.02.027_bb0175","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.annemergmed.2018.04.027","article-title":"Intramuscular midazolam, olanzapine, ziprasidone, or haloperidol for treating acute agitation in the emergency department","volume":"72","author":"Klein","year":"2018","journal-title":"Ann Emerg Med"},{"key":"10.1016\/j.ajem.2026.02.027_bb0180","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1016\/j.annemergmed.2024.05.006","article-title":"Comparing intubation rates in patients receiving parenteral olanzapine with and without a parenteral benzodiazepine in the emergency department","volume":"84","author":"Cole","year":"2024","journal-title":"Ann Emerg Med"},{"key":"10.1016\/j.ajem.2026.02.027_bb0185","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1097\/PEC.0000000000001231","article-title":"The use, safety, and efficacy of olanzapine in a level I pediatric trauma center emergency department over a 10-year period","volume":"36","author":"Cole","year":"2020","journal-title":"Pediatr Emerg Care"},{"key":"10.1016\/j.ajem.2026.02.027_bb0190","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.annemergmed.2021.01.005","article-title":"A prospective study of intramuscular Droperidol or olanzapine for acute agitation in the emergency department: a natural experiment owing to drug shortages","volume":"78","author":"Cole","year":"2021","journal-title":"Ann Emerg Med"},{"key":"10.1016\/j.ajem.2026.02.027_bb0195","series-title":"Human research protection criteria for QA\/QI determinations","author":"Hart","year":"2021"},{"key":"10.1016\/j.ajem.2026.02.027_bb0200","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1111\/j.1742-6723.2011.01484.x","article-title":"Sedation assessment tool to score acute behavioural disturbance in the emergency department","volume":"23","author":"Calver","year":"2011","journal-title":"Emerg Med Australas"},{"key":"10.1016\/j.ajem.2026.02.027_bb0205","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1016\/j.ajem.2006.12.002","article-title":"The association of a decreased level of awareness and blood alcohol concentration with both agitation and sedation in intoxicated patients in the ED","volume":"25","author":"Miner","year":"2007","journal-title":"Am J Emerg Med"},{"key":"10.1016\/j.ajem.2026.02.027_bb0210","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/j.annemergmed.2010.05.037","article-title":"Randomized controlled trial of intramuscular droperidol versus midazolam for violence and acute behavioral disturbance: the DORM study","volume":"56","author":"Isbister","year":"2010","journal-title":"Ann Emerg Med"},{"key":"10.1016\/j.ajem.2026.02.027_bb0215","doi-asserted-by":"crossref","first-page":"292","DOI":"10.29252\/beat-060404","article-title":"Effect of intramuscular ketamine versus haloperidol on short-term control of severe agitated patients in emergency department; a randomized clinical trial","volume":"6","author":"Heydari","year":"2018","journal-title":"Bull Emerg Trauma"},{"key":"10.1016\/j.ajem.2026.02.027_bb0220","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1111\/acem.14124","article-title":"Randomized double-blind trial of intramuscular Droperidol, ziprasidone, and lorazepam for acute undifferentiated agitation in the emergency department","volume":"28","author":"Martel","year":"2021","journal-title":"Acad Emerg Med"},{"key":"10.1016\/j.ajem.2026.02.027_bb0225","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/S0736-4679(98)00045-6","article-title":"Chemical restraint for the agitated patient in the emergency department: lorazepam versus droperidol","volume":"16","author":"Richards","year":"1998","journal-title":"J Emerg Med"},{"key":"10.1016\/j.ajem.2026.02.027_bb0230","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.annemergmed.2016.07.033","article-title":"Midazolam-Droperidol, Droperidol, or Olanzapine for Acute Agitation: A Randomized Clinical Trial","volume":"69","author":"Taylor","year":"2017","journal-title":"Ann Emerg Med"},{"key":"10.1016\/j.ajem.2026.02.027_bb0235","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.annemergmed.2012.07.118","article-title":"Intravenous droperidol or olanzapine as an adjunct to midazolam for the acutely agitated patient: a multicenter, randomized, double-blind, placebo-controlled clinical trial","volume":"61","author":"Chan","year":"2013","journal-title":"Ann Emerg Med"},{"key":"10.1016\/j.ajem.2026.02.027_bb0240","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.annemergmed.2005.07.003","article-title":"Randomized clinical trial comparing intravenous midazolam and droperidol for sedation of the acutely agitated patient in the emergency department","volume":"47","author":"Knott","year":"2006","journal-title":"Ann Emerg Med"},{"key":"10.1016\/j.ajem.2026.02.027_bb0245","first-page":"1167","article-title":"Management of acute undifferentiated agitation in the emergency department: a randomized double-blind trial of droperidol, ziprasidone, and midazolam","volume":"12","author":"Martel","year":"2005","journal-title":"Acad Emerg Med"},{"key":"10.1016\/j.ajem.2026.02.027_bb0250","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2021.100751","article-title":"Intramuscular midazolam, olanzapine, or haloperidol for the management of acute agitation: a multi-Centre, double-blind, randomised clinical trial","volume":"32","author":"Chan","year":"2021","journal-title":"EClinicalMedicine"},{"key":"10.1016\/j.ajem.2026.02.027_bb0255","doi-asserted-by":"crossref","first-page":"1880","DOI":"10.1016\/j.ajem.2019.01.001","article-title":"Antipsychotics for the treatment of sympathomimetic toxicity: a systematic review","volume":"37","author":"Connors","year":"2019","journal-title":"Am J Emerg Med"},{"key":"10.1016\/j.ajem.2026.02.027_bb0260","doi-asserted-by":"crossref","first-page":"345","DOI":"10.3109\/15563650.2016.1142090","article-title":"Treatment of cocaine cardiovascular toxicity: a systematic review","volume":"54","author":"Richards","year":"2016","journal-title":"Clin Toxicol"},{"key":"10.1016\/j.ajem.2026.02.027_bib346","doi-asserted-by":"crossref","unstructured":"Isoardi KZ, Cole JB, Hoffman RS, Isbister GK. What is the best approach for parenteral sedation to manage severe acute behavioral disturbance in the emergency department? Clin Toxicol (Phila). 2025 Dec 8:1-7. doi:10.1080\/15563650.2025.2591356. Online ahead of print","DOI":"10.1080\/15563650.2025.2591356"},{"key":"10.1016\/j.ajem.2026.02.027_bb0265","first-page":"744","article-title":"A prospective, double-blind, randomized trial of midazolam versus haloperidol versus lorazepam in the chemical restraint of violent and severely agitated patients","volume":"11","author":"Nobay","year":"2004","journal-title":"Acad Emerg Med"},{"key":"10.1016\/j.ajem.2026.02.027_bb0270","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.jemermed.2024.07.005","article-title":"Rescue sedation after 5 mg or 10 mg of Droperidol as the initial treatment for acute agitation in the emergency department","volume":"68","author":"Cole","year":"2025","journal-title":"J Emerg Med"},{"key":"10.1016\/j.ajem.2026.02.027_bb0275","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.ajem.2023.11.059","article-title":"Involuntary sedation of patients in the emergency department for mental health: a retrospective cohort study","volume":"77","author":"Southerland","year":"2024","journal-title":"Am J Emerg Med"},{"key":"10.1016\/j.ajem.2026.02.027_bb0280","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajem.2020.04.013","article-title":"Efficacy of ketamine for initial control of acute agitation in the emergency department: a randomized study","author":"Lin","year":"2021","journal-title":"Am J Emerg Med"},{"key":"10.1016\/j.ajem.2026.02.027_bb0285","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/S0735-6757(97)90119-4","article-title":"Haloperidol, lorazepam, or both for psychotic agitation? A multicenter, prospective, double-blind, emergency department study","volume":"15","author":"Battaglia","year":"1997","journal-title":"Am J Emerg Med"},{"key":"10.1016\/j.ajem.2026.02.027_bb0340","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1097\/00000542-200108000-00007","article-title":"A double-blind, randomized comparison of i.v. lorazepam versus midazolam for sedation of ICU patients via a pharmacologic model","volume":"95","author":"Barr","year":"2001","journal-title":"Anesthesiology"},{"issue":"Suppl. 2","key":"10.1016\/j.ajem.2026.02.027_bb0345","doi-asserted-by":"crossref","first-page":"S12","DOI":"10.1016\/S0924-9338(10)71701-6","article-title":"From receptor pharmacology to improved outcomes: individualising the selection, dosing, and switching of antipsychotics","volume":"25","author":"Correll","year":"2010","journal-title":"Eur Psychiatry"},{"key":"10.1016\/j.ajem.2026.02.027_bb0290","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1111\/acem.13486","article-title":"Parenteral antipsychotic choice and its association with emergency department length of stay for acute agitation secondary to alcohol intoxication","volume":"26","author":"Cole","year":"2019","journal-title":"Acad Emerg Med"},{"key":"10.1016\/j.ajem.2026.02.027_bb0295","doi-asserted-by":"crossref","first-page":"728","DOI":"10.5811\/westjem.2020.4.47036","article-title":"The incidence of QT prolongation and Torsades des pointes in patients receiving Droperidol in an urban emergency department","volume":"21","author":"Cole","year":"2020","journal-title":"West J Emerg Med"},{"key":"10.1016\/j.ajem.2026.02.027_bb0300","doi-asserted-by":"crossref","first-page":"433","DOI":"10.4088\/JCP.08m04411gry","article-title":"Case reports of postmarketing adverse event experiences with olanzapine intramuscular treatment in patients with agitation","volume":"71","author":"Marder","year":"2010","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.ajem.2026.02.027_bb0305","doi-asserted-by":"crossref","first-page":"500","DOI":"10.4088\/JCP.v64n0502","article-title":"A review of the safety and efficacy of droperidol for the rapid sedation of severely agitated and violent patients","volume":"64","author":"Shale","year":"2003","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.ajem.2026.02.027_bb0310","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/S0196-0644(05)82660-5","article-title":"Droperidol versus haloperidol for chemical restraint of agitated and combative patients","volume":"21","author":"Thomas","year":"1992","journal-title":"Ann Emerg Med"},{"key":"10.1016\/j.ajem.2026.02.027_bb0315","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1016\/j.jemermed.2018.12.036","article-title":"Rescue sedation when treating acute agitation in the emergency department with intramuscular antipsychotics","volume":"56","author":"Klein","year":"2019","journal-title":"J Emerg Med"},{"key":"10.1016\/j.ajem.2026.02.027_bb0320","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.ajem.2017.06.043","article-title":"A brief assessment of capacity to consent instrument in acutely intoxicated emergency department patients","volume":"36","author":"Martel","year":"2018","journal-title":"Am J Emerg Med"},{"key":"10.1016\/j.ajem.2026.02.027_bb0325","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1111\/acem.13673","article-title":"Study enrollment when \u201cpreconsent\u201d is utilized for a randomized clinical trial of two treatments for acute agitation in the emergency department","volume":"26","author":"Cole","year":"2019","journal-title":"Acad Emerg Med"},{"key":"10.1016\/j.ajem.2026.02.027_bb0330","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/j.annemergmed.2018.05.025","article-title":"Ethics and regulatory barriers to research in emergency settings","volume":"72","author":"Dickert","year":"2018","journal-title":"Ann Emerg Med"},{"key":"10.1016\/j.ajem.2026.02.027_bb0335","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.annemergmed.2015.03.016","article-title":"The safety and effectiveness of Droperidol for sedation of acute behavioral disturbance in the emergency department","volume":"66","author":"Calver","year":"2015","journal-title":"Ann Emerg Med"}],"container-title":["The American Journal of Emergency Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0735675726000999?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0735675726000999?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T22:30:27Z","timestamp":1776897027000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0735675726000999"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":70,"alternative-id":["S0735675726000999"],"URL":"https:\/\/doi.org\/10.1016\/j.ajem.2026.02.027","relation":{},"ISSN":["0735-6757"],"issn-type":[{"value":"0735-6757","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Intramuscular droperidol, olanzapine, midazolam, or lorazepam to treat methamphetamine intoxication in the emergency department","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Emergency Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajem.2026.02.027","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}